期刊文献+

老年高血压合并心衰的危险因素分析 被引量:13

Risk factors analysis of hypertension with heart failure in geriatric age patients
暂未订购
导出
摘要 目的探讨老年高血压合并心力衰竭的危险因素,为减少心衰发生,减少致残率、致死率提供依据。方法回顾性调查老年高血压病患者235例,对100例合并心衰者(观察组)与135例未合并心衰者(对照组)进行Logistic回归分析。结果多因素Logistic逐步回归分析显示:血压达标,合并感染,合并高尿酸血症,左室肥厚,吸烟对高血压合并心衰的影响有显著意义(P<0.05)。结论积极控制老年高血压,增加血压达标率,控制左室肥厚,同时控制高血脂高尿酸血症等危险因素对减少老年高血压病患者心衰的发生减少致残率、致死率有积极意义。 Objective To explore the risk factors of hypertension with heart failure in the elderly and to provide the basis in reducing disability and mortality in patients of old age. Methods We retrospectively investigated 235 older adults with hypertension.The patients were divided into two groups based on different situations:100 patients of hypertension with heart failure(observation group)135 patients of hypertension without heart failure(comparative group)Logistic regression analysis was done on these two groups of patients. Results Multi-factor Logistic regression analysis has shown that many factors are of great significance in the patients of hypertension with heart failure.(P0.05)These contributory factors are as follows:the reaching standard rate of blood pressure, the combination of hypertension with infections/hyperlipidaemia/hyperuricaemia, hypertrophy of left ventricular, smoking. Conclusion Our conclusion is that some therapeutic methods are of great importance in lowering the incidence of the heart failure in old patients of hypertension as well as reducing disability and mortality.These methods are as follows:Actively controlling blood pressure in the very elderly, enhancing the reaching standard rate of blood pressure, curbing the risk factors such as LVH(left ventricular hypertrophy), hyperlipidaemia and hyperuricaemia.
出处 《中国实用医药》 2011年第2期38-39,共2页 China Practical Medicine
关键词 心力衰竭 老年 高血压 危险因素 Heart failure Geriatric Hypertension Risk factors
  • 相关文献

参考文献3

二级参考文献12

  • 1Cleland JG, Clark A. Has the survival of the heart failure population changed? Lessons from trials. Am J Cardiol, 1999,83:112D-119D.
  • 2Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J, 1997,133:703-712.
  • 3Gary R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA, 1995,273:1450-1456.
  • 4Cleland JG, Swedberg K, Poole-Wilson PA. Successes and failures of current treatment of heart failure. Lancet, 1998,352:19-28.
  • 5Narang R, Cleland JG, Erhardt L, et al. Mode of death in chronic heart failure: a request for more accurate classification. Eur Heart J, 1996,17:1390-1403.
  • 6Pierpont GL, Cohn JN, Franciosa JA. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside. Chest, 1978,73:8-13.
  • 7Jugdutt BI, Khan MI. Effect of prolonged nitrate therapy on left ventricular remodeling after canine myocardial infarction. Circulation, 1994,89:2297-2307.
  • 8Packer M, O′Connor CM, Ghali JK, et al. Effect of amlodipine on morbidity and mortality in servere chronic heart failure. N Engl J Med, 1996,335:1107-1114.
  • 9Cohn JN, Ziesche S, Smith R, et al. Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-Heft III. Circulation, 1997,96:856-863.
  • 10The Cardiac Insufficiency Bisoprolol Study (CIBIS-II): a randomised trial. Lancet, 1999,353:9-13.

共引文献194

同被引文献93

引证文献13

二级引证文献120

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部